Cure Parkinson’s
19 results.
This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here. It was announced today that the Australian Parkinson's…
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a week ago, the…
Grand Rapids, Mich. (Sept. 25, 2017)—Leading Parkinson’s experts and advocates from around the world will gather at Van Andel Research Institute in…
In less than a month, scientists, physicians and people with Parkinson’s will gather at Van Andel Research Institute with one goal in mind—finding a cure…
Evidence continues to mount that a newer class of anti-diabetic drugs called incretin mimetics, or glucagon-like peptide-1 receptor agonists, could slow…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
New data published today shows drug preserves critical brain function in laboratory models of Parkinson’s GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally…
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…